Question 1

What is the catalog number for Recombinant Salivary Alpha Amylase (AMY1A)?

Accepted Answer

The catalog number for Recombinant Salivary Alpha Amylase (AMY1A) is SIPB133Hu02.

Question 2

What sizes are available for Recombinant Salivary Alpha Amylase (AMY1A)?

Accepted Answer

Recombinant Salivary Alpha Amylase (AMY1A) is available in the following size(s): 10 µg, 50 µg, 200 µg, 1 mg, 5 mg.

Question 3

How many pack sizes does Recombinant Salivary Alpha Amylase (AMY1A) come in?

Accepted Answer

Recombinant Salivary Alpha Amylase (AMY1A) is available in 5 different pack sizes.

Question 4

Is Recombinant Salivary Alpha Amylase (AMY1A) in stock?

Accepted Answer

Recombinant Salivary Alpha Amylase (AMY1A) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 6

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 7

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Recombinant Salivary Alpha Amylase (AMY1A)

Product Specifications

Gene Aliases

Organism

Source

Applications

Purity

Host or Source

Species

Available Sizes

Frequently Asked Questions

Explore Other Products

Annexin A1 / (Hairy Cell Leukemia Marker) (ANXA1/3566), Biotin conjugate, 0.1mg/mL

CD35 / CR1 (E11), CF488A conjugate, 0.1mg/mL

CD45RA (PTPRC/1148), CF740 conjugate, 0.1mg/mL

CD8 (C8/468 + C8/144B), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

CD79a (HM47/A9), CF568 conjugate, 0.1mg/mL